honokiol has been researched along with Periodontal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosokawa, I; Hosokawa, Y; Matsuo, T; Ozaki, K | 1 |
| Chen, CP; Ho, KY; Huang, JS; Lin, CC; Tsai, CC | 1 |
2 other study(ies) available for honokiol and Periodontal Diseases
| Article | Year |
|---|---|
Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells.
Topics: Anti-Inflammatory Agents; Biphenyl Compounds; Chemokine CXCL10; Chemokine CXCL11; Epithelial Cells; Humans; Interleukin-27; Ligands; Lignans; Mouth; Periodontal Diseases; Proto-Oncogene Proteins c-akt; Receptors, CXCR3; STAT3 Transcription Factor | 2018 |
Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis.
Topics: Actinobacillus; Anti-Bacterial Agents; Bacillus; Bacteria; Biphenyl Compounds; Drugs, Chinese Herbal; Humans; Lignans; Magnoliopsida; Microbial Sensitivity Tests; Micrococcus; Periodontal Diseases; Plants, Medicinal; Porphyromonas; Prevotella | 2001 |